Tonix Pharmaceuticals Holding (TNXP) Asset Utilization Ratio (2023 - 2025)
Historic Asset Utilization Ratio for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 0.05.
- Tonix Pharmaceuticals Holding's Asset Utilization Ratio fell 6571.76% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year decrease of 6571.76%. This contributed to the annual value of 0.06 for FY2024, which is N/A changed from last year.
- Tonix Pharmaceuticals Holding's Asset Utilization Ratio amounted to 0.05 in Q3 2025, which was down 6571.76% from 0.05 recorded in Q2 2025.
- Over the past 5 years, Tonix Pharmaceuticals Holding's Asset Utilization Ratio peaked at 0.14 during Q3 2024, and registered a low of 0.05 during Q3 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median Asset Utilization Ratio value was 0.08 (recorded in 2023), while the average stood at 0.08.
- As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Asset Utilization Ratio surged by 164.11% in 2024, and later plummeted by 6571.76% in 2025.
- Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Asset Utilization Ratio stood at 0.08 in 2023, then increased by 1.64% to 0.08 in 2024, then plummeted by 40.17% to 0.05 in 2025.
- Its Asset Utilization Ratio stands at 0.05 for Q3 2025, versus 0.05 for Q2 2025 and 0.06 for Q1 2025.